These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6830329)

  • 1. Effect of a specific iron chelating agent on animal models of inflammation.
    Blake DR; Hall ND; Bacon PA; Dieppe PA; Halliwell B; Gutteridge JM
    Ann Rheum Dis; 1983 Feb; 42(1):89-93. PubMed ID: 6830329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of microsomal oxidation of alcohols and of hydroxyl-radical-scavenging agents by the iron-chelating agent desferrioxamine.
    Cederbaum AI; Dicker E
    Biochem J; 1983 Jan; 210(1):107-13. PubMed ID: 6303308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine.
    Gutteridge JM; Richmond R; Halliwell B
    Biochem J; 1979 Nov; 184(2):469-72. PubMed ID: 230833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the iron chelating agent desferrioxamine on two rat inflammatory models.
    Hirschelmann R; Bekemeier H
    Free Radic Res Commun; 1986; 2(1-2):125-7. PubMed ID: 3505237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin-iron catalysed phospholipid peroxidation: a reaction not involving reduced adriamycin or hydroxyl radicals.
    Gutteridge JM
    Biochem Pharmacol; 1983 Jun; 32(12):1949-52. PubMed ID: 6309187
    [No Abstract]   [Full Text] [Related]  

  • 6. Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical.
    Andorn AC; Britton RS; Bacon BR
    J Neurochem; 1996 Aug; 67(2):717-22. PubMed ID: 8764600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation and inhibition of iron-dependent lipid peroxidation by desferrioxamine.
    Braughler JM; Chase RL; Pregenzer JF
    Biochem Biophys Res Commun; 1988 Jun; 153(3):933-8. PubMed ID: 3390189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies into the effects of the iron chelator desferrioxamine on the inflammatory process.
    Sedgwick AD; Blake DR; Winwood P; Moore AR; Al-Duaij A; Willoughby DA
    Eur J Rheumatol Inflamm; 1984; 7(3):87-94. PubMed ID: 6571264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prooxidant activity of ferrioxamine in isolated rat hepatocytes and linoleic acid micelles.
    Bergamini S; Rota C; Staffieri M; Tomasi A; Iannone A
    Chem Res Toxicol; 1999 Apr; 12(4):365-70. PubMed ID: 10207126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation.
    Reeder BJ; Wilson MT
    Chem Res Toxicol; 2005 Jun; 18(6):1004-11. PubMed ID: 15962935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferrous ion-EDTA-stimulated phospholipid peroxidation. A reaction changing from alkoxyl-radical- to hydroxyl-radical-dependent initiation.
    Gutteridge JM
    Biochem J; 1984 Dec; 224(3):697-701. PubMed ID: 6441569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant capacity of desferrioxamine and ferrioxamine in the chemically-initiated lipid peroxidation of rat erythrocyte ghost membranes.
    Videla LA; Cáceres T; Lissi EA
    Biochem Int; 1988 May; 16(5):799-807. PubMed ID: 3421981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of desferrioxamine on antigen-induced inflammation in the rat air pouch.
    Yoshino S; Blake DR; Bacon PA
    J Pharm Pharmacol; 1984 Aug; 36(8):543-5. PubMed ID: 6148399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine.
    Muntané J; Puig-Parellada P; Mitjavila MT
    J Lab Clin Med; 1995 Nov; 126(5):435-43. PubMed ID: 7595028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of iron in carrageenan-induced granuloma: action of desferrioxamine and indometacin.
    Mitjavila MT; Carbonell MT; Sáiz MP; Muntané J; Sánchez J; Puig-Parellada P
    Pharmacology; 1990; 40(4):236-40. PubMed ID: 2388929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desferrioxamine as a lipid chain-breaking antioxidant in sickle erythrocyte membranes.
    Hartley A; Davies M; Rice-Evans C
    FEBS Lett; 1990 May; 264(1):145-8. PubMed ID: 2159892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum.
    Obata T
    Eur J Pharmacol; 2006 Jun; 539(1-2):34-8. PubMed ID: 16650845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
    Burkitt MJ; Kadiiska MB; Hanna PM; Jordan SJ; Mason RP
    Mol Pharmacol; 1993 Feb; 43(2):257-63. PubMed ID: 8381512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts.
    Gutteridge JM; Quinlan GJ; Clark I; Halliwell B
    Biochim Biophys Acta; 1985 Jul; 835(3):441-7. PubMed ID: 2861853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lipid peroxidation by a new family of iron chelators. Comparison with desferrioxamine.
    Rachidi S; Coudray C; Baret P; Gelon G; Pierre JL; Favier A
    Biol Trace Elem Res; 1994; 41(1-2):77-87. PubMed ID: 7946911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.